We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

7 hedge funds and large institutions have $101K invested in NeuroMetrix, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

40% more funds holding

Funds holding: 57 (+2)

17% more capital invested

Capital invested by funds: $86K → $101K (+$15K)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
WS
1
Wedbush Securities
California
$59K +$26.9K +1,780 +69%
Vanguard Group
2
Vanguard Group
Pennsylvania
$27K
UBS Group
3
UBS Group
Switzerland
$10K +$10.9K +722 New
BlackRock
4
BlackRock
New York
$3K
TRCT
5
Tower Research Capital (TRC)
New York
$2K +$2.76K +183 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
-$8K -500 Closed
Wells Fargo
7
Wells Fargo
California
+$30 +2 +200%
ASN
8
Advisory Services Network
Georgia
+$196 +13 New

NURO Hedge Fund Activity: Q3 2020 in Review

7 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2020, worth a combined $101K — up 17% from $86K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NURO positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Wedbush Securities, adding an estimated $26.9K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $8K sold.

  • 7 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2020, up from 5 in Q2 2020.
  • Funds reported $101K of NeuroMetrix, Inc. Common Stock stock for Q3 2020, up 17% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2020 and 1 closed out, a net change of +2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2020 was Wedbush Securities, an estimated $26.9K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q3 2020 was Royal Bank of Canada, an estimated $8K sold.

Based on aggregated 13F filings for Q3 2020.